Streptomycin and isoniazid are the most effective drugs in the treatment of tuberculosis. There are many reports on isoniazid dosage from 200 to 1,000 mg. daily but few on the optimal dose of streptomycin.
A daily dose of 1 g. has become widely accepted, especially as toxicity is low in young patients receiving this drug for only three to six months. More recently, dissatisfaction with the self-administration of para-aminosalicylic acid (P.A.S.) and recourse to streptomycin and isoniazid for longer periods in elderly patients has shown that labyrinthine damage due to streptomycin is a troublesome and serious complication. The prolonged use of streptomycin and isoniazid made it desirable to explore methods for diminishing the incidence of labyrinthine damage without loss of therapeutic efficiency. Reduction of the dose of streptomycin to 0.75 g. daily appeared to be a reasonable compromise, and preliminary results have already been reported (Johnston et al., 1961) . Penman et al. (1957) found that pantothenic acid alleviated the vertigo of streptomycin. We were unable to trace any reports on the use of pantothenic acid to prevent labyrinthine damage due to streptomycin. We therefore decided to explore this possibility, to study 0.75 g. of streptomycin and high-dosage isoniazid. With this background we planned the following controlled clinical trial in 1958.
Method
All new patients over the age of 15 years admitted to hospital with active pulmonary tuberculosis were accepted with the following exclusions : previous antituberculous chemotherapy, primary tuberculosis, diabetes mellitus, pneumoconiosis, nonEuropeans, and expectant mothers. From November 1958 to December 1959 138 patients were accepted. When a patient was admitted to the trial the name was forwarded to a central secretary, who chose a card at random from a series specifying one of the following three regimens:
(1) S.I.= Streptomycin sulphate 1 g. Initial examination in hospital included a radiograph of chest, tomography, and a minimum of three sputum specimens or laryngeal swabs. The former were stained for acid-fast bacilli and cultured on Loewenstein-Jensen media for Mycobacterium tuberculosis. Sensitivity tests were performed to streptomycin, P.A.S., and isoniazid on all positive cultures, using solid media, and all tests were performed against the standard H.37 Rv. strain. In the case of streptomycin and P.A.S. the organism was regarded as resistant if the test strain was four or more times resistant to the drug, compared with the H.37 Rv. culture. Resistance to isoniazid was shown by a growth -of more than 20 colonies on the tube containing 0.2 jug of isoniazid per ml. In addition to routine ward tests the urine was examined in the central laboratory for protein together with microscopy of the deposit. Renal function was further assessed by the blood urea and measurements of the streptomycin serum levels at 1 hour and 24 hours after the streptomycin injection. These latter bio-assays were performed after the P.A.S. had been discontinued and using the same strain of Klebsiella pneumoniae known to be streptomycinsensitive. The E.S.R. was measured by the Westergren method. Subsequently two sputum smears and cultures were examined every two weeks until discharge, with radiographs of chest and E.S.R. monthly.
At three-monthly intervals from the start of treatment, in addition to the above, clinical examination included the Romberg test, examination for nystagmus, and observations of the patient's gait. Later we reinforced the Romberg test by asking the patient to " about turn " with closed eyes and heels together. When a patient complained of dizziness or a tendency to stagger, these tests were repeated, and included the Hallpike caloric test (Hallpike, 1956 Most of the patients attended the chest clinic subsequently for streptomycin and isoniazid. A daily register was kept of their attendance during the ensuing 12 to 15 months. Fourteen patients received their treatment at home from the district nurse, and 10 at a hospital close to their homes. In these 24 no register was kept. The nurses concerned reported those who failed to have their treatment. During their summer holidays most of the patients reverted to 12 g. of P.A.S. and 200 mg. of isoniazid daily in a combined cachet for two weeks, but a few patients preferred to continue their streptomycin and isoniazid. All patients were re-examined at three-monthly intervals, and examination included a radiograph, E.S.R., and two sputa or laryngeal swabs cultured for M. tuberculosis. Patients were encouraged to report any untoward symptoms. Chemotherapy was continued for 18 months in all except one patient (S.4 group) who received two and a half years' chemotherapy, with the last nine months on P.A.S. and isoniazid only. Thereafter, patients were seen at six-monthly intervals, with a special review two years after stopping treatment, and at that time caloric tests were arranged for all those who were willing to attend. The study now extends to five years' observation on the earliest patients.
Distribution of Patients
The figures in Table I show that the patients in each treatment group were moderately well matched except for the S.I. group, where the disease area was greater and the average cavity size larger. The youngest patient was 16 years and the oldest 85. The oldest to complete treatment was 70 (S.4). 
Withdrawals
There were 138 patients in the initial trial and 37 in the later stage-a total of 175. The reasons for withdrawal are shown in Table II . years showed a trend in favour of those in the S.I. group. There were more patients with a residual disability in the S.P. group.
(7) The serum-streptomycin levels have been of little value (Table IV) At the final review we arranged caloric tests for all the patients who were willing to attend, and 89 were examined. One patient showed an absent response and four a sluggish response, but none of these complained of any residual disability. One patient (S.I.) with no response had not had earlier caloric tests but had suffered vertigo and treatment was stopped. Of the other four, three had developed vertigo (two S.I. and one S.P.) and one (S.#) had no record of previous vertigo. Thus there was only one instance of "silent" labyrinthine damage.
At the final review five patients showed a residual disability and had caloric tests which were abnormal in four. In two of these four the usual tests at 30' and 400 C. gave equivocal results, and evidence of labyrinthine damage was found only by repeating the test with water at 200 C.
Isoniazid Psychosis
Isoniazid psychosis developed in two patients in the S.I. group. (The second patient was withdrawn because of vestibular damage and therefore only one patient is shown in Table  II .) Their mental symptoms resolved when the dose of isoniazid was reduced to 200 mg. daily.
High-tone Deafness
This was observed in only one patient-a man aged 33 (group S.I.) who complained of slight deafness three months after the start of treatment. Audiograms showed a marked high-tone deafness on both sides and caloric tests some disturbance of vestibular function. There were no signs of abnormal renal function and the blood-urea and serum-streptomycin levels were normal.
Diagnosis in Doubt or Error
Five patients were withdrawn because of doubt or error in diagnosis-one suffering from bronchial carcinoma, two with quiescent pulmonary tuberculosis, one with aspergillosis, and one with an atypical mycobacterial infection.
Refusal of Treatment
Eighteen patients refused treatment-one at eight months, 13 on discharge from hospital, and another four at one to five months after discharge from hospital. Most of these patients were intellectually backward. Other reasons for failure were resumption of work and travelling for treatment, especially in Association (1961) classification: the size of cavities was recorded in centimetres and when more than one. was present the total diameters were added together. In addition, an independent assessment of the area of disease present on the postero-anterior film was made, using a transparent grid ruled in 1-cm. squares. The films taken 6, 12, and 18 months after the start of treatment were compared with the original, and also a film taken two years after the cessation of treatment. The degree of improvement was recorded as slight improvement (1 +), moderate improvement (2+), considerable improvement (3 +), and exceptional improvement (4 +). The results in Table VI for the readings at 6, 12, and 18 months represent the average index of improvement obtained by summing these Simpson (1956) , Dixon et al. (1957) , and others. R. T. Ritchie (personal communication, 1958) confirmed these findings in 487 Dundee patients. All these reports are based on random urine tests which show that chemotherapy is sometimes omitted but does not define the frequency. (Penman et al., 1957) , 30% (Mahady et al., 1953) , and 60% (Sita Lumsden and Powell, 1953 There is some evidence that daily streptomycin + isoniazid is not essential beyond a year, and an intermittent regime may be adequate in the later stages of treatment.
Two decades of advance in surgical techniques and management have permitted the cancer surgeon to perform massive local resections of tissue and increasingly extensive block dissections of the lymphatic pathways. In addition, with a more enlightened general public and greater diagnostic facilities, early diagnosis of cancer is becoming increasingly common. Nevertheless, the overall mortality from cancer remains very much the same as it was 25 years ago, the patients continuing to die from distant metastases. There is therefore increasing interest in the mechanisms of tumour dissemination and the means of preventing it.
Circulating cancer cells were first described by Ashworth in 1869, and further observations were made by Loeper and Louste (1904) , Schleip (1906) , Ward (1913) , Marcus (1917) , Quensel (1921) , and Pool and Dunlop (1934) . Pool 
